Market Access & Pricing Strategy

Translating clinical value into market access—aligning price, positioning, and payer expectations for long-term success with a marketing-driven approach.

We help pharmaceutical companies navigate market access challenges and build value-based pricing strategies—ensuring product availability, payer alignment, and sustainable commercial success.

A strong product needs more than clinical data—it requires a clear and credible value story tailored to local systems, stakeholders, and healthcare realities. We support teams from pre-launch through reimbursement and post-access optimization.

Our services include:

Reimbursement Landscape Analysis

Assessment of the regulatory, payer, and access environment in key markets to inform go-to-market strategy.

Value Proposition & Evidence Strategy

Development of compelling value narratives supported by clinical and economic data aligned with payer expectations.

Health Technology Assessment (HTA) Preparation

Guidance and documentation support to meet HTA requirements and communicate therapeutic and economic benefits.

Pricing Strategy & Scenario Planning

Modeling of optimal pricing corridors, competitor benchmarks, and forecast-based recommendations.

Negotiation Support & Stakeholder Materials

Preparation of value dossiers, budget impact models, and communication tools to support payer and institutional negotiations.